Nigel Crawford

Nigel Crawford is a Senior Clinical Director for Early Oncology Development at Sanofi, where they lead the clinical strategy for a novel immuno-oncology asset targeting solid tumors. With over 7 years of experience in early clinical development, they have previously held roles at the National Cancer Institute, National Human Genome Research Institute, and Daiichi Sankyo, contributing to significant advancements in cancer research and treatment. Nigel earned a Ph.D. in Physiology and Biophysics from the University of Louisville and a medical degree from the University of Liverpool.